Johnson & Johnson Stock Faces Tuesday Test After Fresh Talc Verdict as Dividend Date Nears

Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J

Verdict comes as lawyers prepare for the first federal talcum powder trials to go before a jury, involving claims that will be repeated in tens of thousands of ovarian cancer lawsuits being pursued by women in the federal court system. A Pennsylvania jury has ordered Johnson & Johnson to pay a family $250,000 in a talcum powder lawsuit that went to trial in s…

Johnson & Johnson stock faces Tuesday test after fresh talc verdict as dividend date nears

A Pennsylvania jury found Johnson & Johnson liable in a baby powder talc cancer case, awarding $250,000 to the plaintiff’s family. Shares closed at $243.45 Friday, down 0.45%. U.S. markets are closed Monday for Presidents Day. The company plans to appeal the verdict and faces over 67,000 similar lawsuits. The post Johnson & Johnson stock faces Tuesday test after fresh talc verdict as dividend date nears appeared first on TechStock².

Johnson & Johnson Faces New Talc Trial Loss as Jury Awards Damages

A Pennsylvania jury ordered Johnson & Johnson to pay $250,000 in a new talc baby powder ovarian cancer trial loss.